Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine
- Status
- COMPLETED
- Phase
- PHASE4
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride
- Status
- COMPLETED
- Phase
- PHASE4
Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE4
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis
- Status
- UNKNOWN
- Phase
- PHASE3
Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology
- Status
- COMPLETED
- Phase
- PHASE3
An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Rasburicase in Patients at Risk for Tumor Lysis Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
- Status
- TERMINATED
- Phase
- PHASE4
Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin
- Status
- COMPLETED
- Phase
- PHASE4
Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3